DrugPatentWatch Database Preview
Romiplostim - Biologic Drug Details
Summary for romiplostim
| Tradenames: | 1 |
| Patents: | 19 |
| Applicants: | 1 |
| BLAs: | 1 |
| Suppliers: see list | 1 |
Pharmacology for romiplostim
| Mechanism of Action | Thrombopoietin Receptor Agonists |
| Physiological Effect | Increased Megakaryocyte Maturation Increased Platelet Production |
US Patents for romiplostim
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amgen | NPLATE | romiplostim | INJECTABLE; SUBCUTANEOUS | 125268 | 001 | 2008-08-22 | Start Trial | SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) | 2033-03-11 | RX | search | |
| Amgen | NPLATE | romiplostim | INJECTABLE; SUBCUTANEOUS | 125268 | 001 | 2008-08-22 | Start Trial | University of the Sciences of Philadelphia (Philadelphia, PA) | 2034-11-21 | RX | search | |
| Amgen | NPLATE | romiplostim | INJECTABLE; SUBCUTANEOUS | 125268 | 001 | 2008-08-22 | Start Trial | 2038-10-10 | RX | search | ||
| Amgen | NPLATE | romiplostim | INJECTABLE; SUBCUTANEOUS | 125268 | 001 | 2008-08-22 | Start Trial | BAYER INTELLECTUAL PROPERTY GMBH (Monheim, DE) | 2031-04-05 | RX | search | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patents for romiplostim
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Canada | 2346996 | Start Trial |
| China | 1781945 | Start Trial |
| Japan | 2002536960 | Start Trial |
| Australia | 5943201 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for romiplostim
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 1124961/01 | Switzerland | Start Trial | FORMER REPRESENTATIVE: BOHEST AG, CH |
| C/GB09/035 | United Kingdom | Start Trial | SUPPLEMENTARY PROTECTION CERTIFICATE NO SPC/GB09/035 GRANTED TO KIRIN-AMGEN INC. IN RESPECT OF THE PRODUCT ROMIPLOSTIM, THE GRANT OF WHICH WAS ADVERTISED IN JOURNAL NO 6361 DATED 20/04/2011 HAS HAD ITS MAXIMUM PERIOD OF DURATION CORRECTED, SUBJECT TO THE PAYMENT OF THE PRESCRIBED FEES IT WILL EXPIRE ON 05/02/2024. |
| 6 | Finland | Start Trial | |
| 2009006 | Lithuania | Start Trial | PRODUCT NAME: ROMIPLOSTIMUM; REGISTRATION NO/DATE: EU/1/08/497/001-002 20090204 |
| >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
